Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06287112

Prevention of Acute Cholecystitis With ETGBD

Efficacy of ETGBD Parallel Insertion With Fully Covered Self-expandable Metal Stent for Preventing Acute Cholecystitis in Patients With Low Cystic Duct Insertion

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
35 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn about Efficacy of the ETGBD parallel insertion with fully covered self-expandable metal stent for preventing acute cholecystitis in patients with low cystic duct insertion. In this study, we hypothesized that endoscopic transpapillary gallbladder drainage (ETGBD) with parallel insertion of a fully covered self-expanding metal stent(FCSEMS) through an endoscopic biliary drainage tunnel is superior in preventing complications such as cholecystitis when the gallbladder ducts confluence within the distal third of the common bile duct. And we aimed to confirm its efficacy by comparing the frequency, severity, and rate of invasive additional procedures due to cholecystitis complications to provide evidence of clinical utility.

Conditions

Interventions

TypeNameDescription
DEVICEEndoscopic transpapillary gallbladder drainage (ETGBD)Fully covered self-Expandable metal stent with Endoscopic transpapillary gallbladder drainage (ETGBD) in patient with cystic duct low insertion

Timeline

Start date
2024-06-20
Primary completion
2027-02-20
Completion
2027-03-30
First posted
2024-02-29
Last updated
2025-02-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06287112. Inclusion in this directory is not an endorsement.